SEC 13F Intelligence

Managers / Q2 2024 · view latest →

Sivik Global Healthcare LLC

CIK 0001596452 · 133 TACONIC RD, GREENWICH, CT, 06831 · 203-769-8600

Reported Value
$278M
Q2 2024
Positions
38
Filings on Record
30
2019–present window
Filed
Jul 29, 2024
original filing

Summary

Sivik Global Healthcare LLC reported $278M in U.S.-listed holdings across 38 positions for Q2 2024.

Its largest position, LLY, represents 4.9% of the portfolio.

Compared with Q1 2024, the fund opened 6 new positions and exited 15.

Portfolio Metrics

Turnover
+27.8%
vs prior filed quarter
Top-10 Concentration
+34.2%
share of reported value
Largest Position
+4.9%
Eli Lilly
New / Exited
6 / 15
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $186MQ4 ’18Q1 ’19: $271MQ2 ’19: $414MQ3 ’19: $198MQ4 ’19: $269MQ4 ’19Q1 ’20: $253MQ2 ’20: $302MQ3 ’20: $232MQ4 ’20: $245MQ4 ’20Q1 ’21: $274MQ2 ’21: $512MQ3 ’21: $419MQ4 ’21: $233MQ4 ’21Q1 ’22: $242MQ2 ’22: $176MQ3 ’22: $180MQ4 ’22: $213MQ4 ’22Q1 ’23: $233MQ2 ’23: $428MQ3 ’23: $198MQ4 ’23: $239MQ4 ’23Q1 ’24: $427MQ2 ’24: $278MQ3 ’24: $236MQ4 ’24: $190MQ4 ’24Q1 ’25: $185MQ2 ’25: $368MQ3 ’25: $344MQ4 ’25: $345MQ4 ’25Q1 ’26: $132Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 73.3%Other: 19.6%ADR: 7.1%
  • Common Stock · 73.3% · $204M
  • Other · 19.6% · $55M
  • ADR · 7.1% · $20M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
PUT - SPY 100 @ 545 EXP 07/19/2024NEW+1.0K1.0K+$55M$55M
MRKMERCK & CONEW+65.9K65.9K+$8M$8M
CORCENCORA INCNEW+26.0K26.0K+$6M$6M
AAGILENT TECHNOLOGIES INCNEW+35.0K35.0K+$5M$5M
BRKRBRUKER CORPORATIONNEW+40.0K40.0K+$3M$3M
RGENREPLIGEN CORPNEW+15.0K15.0K+$2M$2M
BIIBBIOGEN INCADDED+20.0K30.0K+$5M$7M
PUT - SPY 100 @ 505 EXP 04/19/2024SOLD OUT−3.0K0−$152M$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2024

37 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1LLYELI LILLY & COhistory →COM4.88%$14M15.0K
2NVONOVO-NORDISK A/Shistory →ADR4.61%$13M90.0K
3MCKMCKESSON CORPhistory →COM3.78%$11M18.0K
4THCTENET HEALTHCAREhistory →COM NEW3.34%$9M70.0K
5BSXBOSTON SCIENTIFIC CORPORATIONhistory →COM3.18%$9M115.0K
6SYKSTRYKER CORPhistory →COM3.06%$9M25.0K
7MRKMERCK & COhistory →COM2.93%$8M65.9K
8HCAHCA HEALTHCARE INChistory →COM2.88%$8M25.0K
9ISRGINTUITIVE SURGhistory →COM NEW2.80%$8M17.5K
10TMOTHERMO FISHER SCIENTIFIC INC.history →COM2.78%$8M14.0K
11DHRDANAHER CORPhistory →COM2.69%$7M30.0K
12UHSUNIV HEALTH SVChistory →CLASS B2.66%$7M40.0K
13VRTXVERTEX PHARMACEUTICALS INC.history →COM2.53%$7M15.0K
14BIIBBIOGEN INChistory →COM2.50%$7M30.0K
15SGRYSURGERY PARTNERS INChistory →COM2.14%$6M250.0K
16CAHCARDINAL HEALTHhistory →COM2.12%$6M60.0K
17CORCENCORA INChistory →COM2.10%$6M26.0K
18BDXBECTON DICKINSON COhistory →COM2.10%$6M25.0K
19RMDRESMEDhistory →COM2.06%$6M30.0K
20EWEDWARDS LIFESCIENCEShistory →COM1.99%$6M60.0K
21ACHCACADIA HEALTHCREhistory →COM1.94%$5M80.0K
22AVTRAVANTOR INChistory →COM1.90%$5M250.0K
23S24SELECT MEDICAL HOLDINGS CORPhistory →COM1.83%$5M145.0K
24PODDINSULET CORPhistory →COM1.81%$5M25.0K
25EHCENCOMPASS HEALTH CORPhistory →COM1.69%$5M55.0K
26AAGILENT TECHNOLOGIES INChistory →COM1.63%$5M35.0K
27WSTWEST PHARMACEUTICAL SERVICES INChistory →COM1.54%$4M13.0K
28SNNSMITH & NEPHEWhistory →SPDN ADR NEW1.33%$4M150.0K
29DXCMDEXCOMhistory →COM1.22%$3M30.0K
30BAXBAXTER INTERNATIONAL INC.history →COM1.20%$3M100.0K
31TEVATEVA PHARM ADRhistory →SPONSORED ADS1.17%$3M200.0K
32NTRANATERA INChistory →COM1.17%$3M30.0K
33MRVIMARAVAI LIFESCIENCES HLDGS-Ahistory →COM CL A1.16%$3M450.0K
34MEDPMEDPACE HOLDINGS INChistory →COM1.11%$3M7.5K
35HUMHUMANA INC.history →COM1.01%$3M7.5K
36BRKRBRUKER CORPORATIONCOM0.92%$3M40.0K
37RGENREPLIGEN CORPCOM0.68%$2M15.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$132M34Apr 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$345M49Jan 21, 202613F-HRchanges · EDGAR ↗
Q3 2025$344M44Oct 23, 202513F-HRchanges · EDGAR ↗
Q2 2025$368M46Jul 25, 202513F-HRchanges · EDGAR ↗
Q1 2025$185M31Apr 22, 202513F-HRchanges · EDGAR ↗
Q4 2024$190M38Jan 23, 202513F-HRchanges · EDGAR ↗
Q3 2024$236M35Nov 6, 202413F-HRchanges · EDGAR ↗
Q2 2024$278M38Jul 29, 202413F-HRchanges · EDGAR ↗
Q1 2024$427M47May 1, 202413F-HRchanges · EDGAR ↗
Q4 2023$239M39Feb 5, 202413F-HRchanges · EDGAR ↗
Q3 2023$198M33Nov 7, 202313F-HRchanges · EDGAR ↗
Q2 2023$428M43Aug 9, 202313F-HRchanges · EDGAR ↗
Q1 2023$233M40May 8, 202313F-HRchanges · EDGAR ↗
Q4 2022$213M39Feb 8, 202313F-HRchanges · EDGAR ↗
Q3 2022$180M41Nov 4, 202213F-HRchanges · EDGAR ↗
Q2 2022$176M38Aug 10, 202213F-HRchanges · EDGAR ↗
Q1 2022$242M49May 9, 202213F-HRchanges · EDGAR ↗
Q4 2021$233M45Feb 8, 202213F-HRchanges · EDGAR ↗
Q3 2021$419M43Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$512M49Aug 10, 202113F-HRchanges · EDGAR ↗
Q1 2021$274M47May 12, 202113F-HRchanges · EDGAR ↗
Q4 2020$245M38Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$232M38Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$302M52Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$253M40May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$269M50Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$198M45Nov 12, 201913F-HRchanges · EDGAR ↗
Q2 2019$414M62Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$271M61May 8, 201913F-HRchanges · EDGAR ↗
Q4 2018$186M48Feb 12, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.